Jiaxin Wang – Trademark Portfolio
Entity Type: 01
Jiaxin Wang has 7 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 2 are successfully registered — a 100% registration rate, with 5 applications currently pending. The portfolio includes marks such as FNIISZI and SYCXHYS. Filings span 4 Nice Classification classes, with the highest activity in Class 5 (Pharmaceuticals) and Class 3 (Cosmetics & Cleaning). This trademark owner is based in Fugou County, Henan.
Dawangzhuang Village, Gucheng
32 Xiaowangzhuang Village
Fugou County, Henan 466000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Jiaxin Wang's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Jiaxin Wang have?
Jiaxin Wang has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 pending.
What trademark classes does Jiaxin Wang file in?
Jiaxin Wang files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 9 (Computers & Electronics), Class 21 (Housewares). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Jiaxin Wang's most well-known trademarks?
Jiaxin Wang's registered trademark portfolio includes well-known marks such as FNIISZI and SYCXHYS. These are among 2 currently registered trademarks in the portfolio.
What is Jiaxin Wang's trademark registration success rate?
Jiaxin Wang has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 5 applications are pending review.